Bionano Genomics Inc (BNGO)

May 19, 2025, 8:00 AM EDT - 18 days ago

Bionano Laboratories Announces a Second Category I CPT Code for OGM Established by the AMA; this one for Use in Whole Genome Analysis for Constitutional Genetic Disorders

May 14, 2025, 7:46 PM EDT - 22 days ago

Bionano Genomics, Inc. (BNGO) Q1 2025 Earnings Call Transcript

May 14, 2025, 4:01 PM EDT - 22 days ago

Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress

May 13, 2025, 8:00 AM EDT - 24 days ago

Bionano Laboratories Announces Publication of the Largest Study To-Date Evaluating Clinical Utility of Optical Genome Mapping Across Multiple Hematologic Malignancies

May 7, 2025, 4:01 PM EDT - 4 weeks ago

Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025

May 2, 2025, 9:30 AM EDT - 4 weeks ago

International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers

Apr 23, 2025, 8:00 AM EDT - 6 weeks ago

Bionano Announces Publication Showing OGM can Provide an Accurate and Cost-Effective Solution for Sizing Large Repeat Expansions in Constitutional Genetic Disease

Apr 8, 2025, 8:00 AM EDT - 2 months ago

Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM

Mar 31, 2025, 8:11 PM EDT - 2 months ago

Bionano Genomics, Inc. (BNGO) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 4:01 PM EDT - 2 months ago

Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025

Mar 24, 2025, 8:00 AM EDT - 2 months ago

Study Using OGM in Neural Tube Defects Reveals Previously Unreported Variants and Candidate Genes with Potential Links to the Devastating Birth Defect

Mar 18, 2025, 8:00 AM EDT - 2 months ago

Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) 2025 Annual Meeting

Mar 14, 2025, 8:00 AM EDT - 3 months ago

Bionano to Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call Webcast on March 31, 2025

Mar 13, 2025, 9:00 AM EDT - 3 months ago

Bionano Announces Publication Reporting First Use of OGM to Detect Chromoanagenesis, a Key Marker of Poor Prognosis in AML

Jan 22, 2025, 4:05 PM EST - 4 months ago

Bionano Announces Effective Date of Reverse Stock Split

Jan 6, 2025, 4:30 PM EST - 5 months ago

Bionano Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Jan 3, 2025, 2:34 PM EST - 5 months ago

Bionano Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Dec 31, 2024, 3:26 PM EST - 5 months ago

Bionano Announces Amendment to Senior Secured Convertible Debentures in Debt Restructuring that Improves Cash Runway

Dec 23, 2024, 8:30 AM EST - 5 months ago

Bionano Announces Publication from Johns Hopkins School of Medicine Showing that OGM Outperformed Multiple Cytogenetic Assays in a Study of Bone and Soft Tissue Tumor Analysis

Nov 13, 2024, 7:11 PM EST - 7 months ago

Bionano Genomics, Inc. (BNGO) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 4:01 PM EST - 7 months ago

Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress

Nov 4, 2024, 4:14 AM EST - 7 months ago

Optical Genome Mapping Market to Witness 26.76% CAGR During 2024-2030 - Consumables and Reagents to Register High Growth - Bionano Genomics, Nucleome Informatics, and Praxis Genomics Dominate the Industry

Oct 31, 2024, 4:30 PM EDT - 7 months ago

Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Oct 31, 2024, 8:10 AM EDT - 7 months ago

Bionano Adjourns Special Meeting of Stockholders to November 27, 2024

Oct 10, 2024, 8:00 AM EDT - 8 months ago

Bionano Announces Preliminary 3Q 2024 Revenues and Cash

Aug 13, 2024, 7:23 PM EDT - 10 months ago

Bionano Genomics, Inc. (BNGO) Canaccord Genuity 44th Annual Growth Conference (Transcript)

Aug 7, 2024, 7:11 PM EDT - 10 months ago

Bionano Genomics, Inc. (BNGO) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 4:01 PM EDT - 10 months ago

Bionano Reports Second Quarter 2024 Results and Highlights Recent Business Progress

Jul 31, 2024, 4:01 PM EDT - 11 months ago

Bionano to Present at the Canaccord Genuity 44th Annual Growth Conference

Jul 8, 2024, 5:25 PM EDT - 11 months ago

Bionano Announces Closing of up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Jul 5, 2024, 8:00 AM EDT - 1 year ago

Bionano Announces up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Jul 2, 2024, 8:00 AM EDT - 1 year ago

Scientific Presentations Highlight OGM's Utility for Cancer Research at Joint Annual Meeting for Three Molecular and Cytogenetic Associations

Jun 20, 2024, 8:00 AM EDT - 1 year ago

Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research

Jun 17, 2024, 4:05 PM EDT - 1 year ago

Bionano Laboratories Announces New Category I CPT Code for OGM Use in Hematological Malignancy Analysis

May 23, 2024, 9:17 AM EDT - 1 year ago

Lab Instrument Industry Update - New Commercial Entrants

AKYA CTKB DHR LAB MASS OMIC QGEN

May 8, 2024, 7:12 PM EDT - 1 year ago

Bionano Genomics, Inc. (BNGO) Q1 2024 Earnings Call Transcript

May 8, 2024, 4:01 PM EDT - 1 year ago

Bionano Reports First Quarter 2024 Results and Highlights Recent Business Progress

Apr 11, 2024, 8:00 AM EDT - 1 year ago

Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing

Apr 4, 2024, 1:44 PM EDT - 1 year ago

Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Apr 3, 2024, 8:00 AM EDT - 1 year ago

Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics

Mar 7, 2024, 8:00 AM EST - 1 year ago

Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Including Live Product Showcase Featuring the Company's New Stratys™ System

Mar 5, 2024, 9:54 PM EST - 1 year ago

Bionano Genomics, Inc. (BNGO) Q4 2023 Earnings Call Transcript

Mar 5, 2024, 4:01 PM EST - 1 year ago

Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024

Feb 29, 2024, 8:00 AM EST - 1 year ago

Bionano to Present at TD Cowen's 44th Annual Health Care Conference

Feb 28, 2024, 8:01 AM EST - 1 year ago

Bionano to Report Fourth Quarter and Year End 2023 Financial Results and Host a Conference Call and Webcast on March 5, 2024

Feb 28, 2024, 8:00 AM EST - 1 year ago

Bionano Announces Amendment to Debt Financing Arrangement to Extend Cash Runway

Jan 31, 2024, 8:00 AM EST - 1 year ago

Bionano to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Jan 24, 2024, 8:00 AM EST - 1 year ago

Bionano Announces Publication of Interim Readout from Second Phase of Clinical Trial Analyzing Optical Genome Mapping as Standard of Care (SOC) for Prenatal Testing

Jan 23, 2024, 8:00 AM EST - 1 year ago

Bionano Announces Full Commercial Release of the Stratys™ System for High Throughput Optical Genome Mapping

Jan 19, 2024, 8:00 AM EST - 1 year ago

Bionano Announces the Final Speaker Lineup for 2024 Symposium with 33 OGM Presentations and Live Panel Discussions Across a Wide Range of Research Applications